CAM
AXDX

Close Asset Management’s Accelerate Diagnostics AXDX Stock Holding History

Close Asset Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16
Closed -$1K – 214
2020
Q4 		$1K Hold
16
– – ﹤0.01% 124
2020
Q3 		$2K Hold
16
– – ﹤0.01% 129
2020
Q2 		$2K Hold
16
– – ﹤0.01% 134
2020
Q1 		$1K Hold
16
– – ﹤0.01% 144
2019
Q4 		$3K Hold
16
– – ﹤0.01% 160
2019
Q3 		$3K Hold
16
– – ﹤0.01% 164
2019
Q2 		$4K Hold
16
– – ﹤0.01% 168
2019
Q1 		$3K Sell
16
-13,558
-100% -$2.54M ﹤0.01% 197
2018
Q4 		$8.71M Buy
13,574
+13,558
+84,738% +$2.01M 0.96% 17
2018
Q3 		$4K Hold
16
– – ﹤0.01% 212
2018
Q2 		$4K Hold
16
– – ﹤0.01% 200
2018
Q1 		$4K Hold
16
– – ﹤0.01% 210
2017
Q4 		$4K Hold
16
– – ﹤0.01% 207
2017
Q3 		$4K Hold
16
– – ﹤0.01% 199
2017
Q2 		$4K Hold
16
– – ﹤0.01% 201
2017
Q1 		$4K Hold
16
– – ﹤0.01% 201
2016
Q4 		$3K Buy
+16
New +$3.8K ﹤0.01% 134

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Close Asset Management's AXDX Position: Q1 2021 in Review

Close Asset Management sold out of Accelerate Diagnostics (AXDX) in Q1 2021, closing a stake of 16 shares — an estimated $1K sold.

Close Asset Management first reported a position in AXDX in Q4 2016 and held it in 17 quarters. The position peaked at $8.71M in Q4 2018. 99 funds tracked by Wall St. Rank hold AXDX as of Q1 2021.

  • Close Asset Management reported no remaining Accelerate Diagnostics position as of Q1 2021 after selling out during the quarter.
  • Close Asset Management sold 16 Accelerate Diagnostics shares in Q1 2021, an estimated $1K.
  • Close Asset Management first reported a position in Accelerate Diagnostics in Q4 2016 and held it in 17 quarters.
  • Close Asset Management's Accelerate Diagnostics position peaked at $8.71M in Q4 2018.
  • 99 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2021.

Based on Close Asset Management's 13F filing for Q1 2021, filed 7 May 2021.